Pasta Salad with Tomatoes From the American Institute for Cancer Research

In their ongoing effort to promote cancer-preventive lifestyle choices, the American Institute for Cancer Research and author Dana Jacobi work together to create delicious and health-conscious dishes that includes the following, pasta salad with tomatoes.

The AICR writes:

Few things pair more perfectly than pasta and tomatoes and few dishes capture the feeling of summer better than cool pasta salad. Best of all, along with its great taste, pasta salad with tomatoes has good nutritional value. The whole-wheat pasta provides a healthy base for the dish, while the balsamic vinegar with its tart flavor gives the dish a crisp taste.

The combination of vinegar, sugar and peppers creates a flavor that is exceptionally pleasant. This fusion enables you to avoid the fat in mixtures like mayonnaise without sacrificing flavor. You can experiment with the red pepper to find the level of zesty bite that appeals to your taste.

The recipe calls for Roma tomatoes, though any variety will do. Roma tomatoes, also known as Italian or Italian plum tomatoes, are pear or egg shaped tomatoes that are meatier and have fewer seeds, so they are good for pasta salads. Tomatoes contain the cancer protective, red pigment called lycopene. The green pepper, abundant in vitamin C, also provides color and its flavor combines well with the tomatoes.

Don't forget, each and every recipe offered by the AICR has been vetted and approved by a registered dietitian (RD).

Pasta Salad with Tomatoes

  • 8 oz. whole-wheat fusilli, farfalle or other small pasta shape, cooked according to directions
  • ¼ cup balsamic vinegar (red or white)
  • 4 Tbsp. finely chopped fresh basil, divided
  • 1 tsp. turbinado sugar, optional
  • Salt and freshly ground black pepper to taste
  • 1/8 tsp. crushed red pepper (or to taste)
  • 3 Tbsp. extra virgin olive oil, divided
  • 4 cloves garlic, minced and divided
  • 1 medium green bell pepper, finely chopped
  • 4 plum or Roma tomatoes, coarsely chopped
  • 1 slice whole-wheat bread (multigrain may be substituted)

Instructions

In bowl, cover and chill pasta.

In large mixing bowl, combine vinegar, 2 tablespoons basil, sugar, salt, pepper, red pepper, 2 tablespoons oil and half of minced garlic. Whisk to combine well. Add pasta, bell pepper and tomatoes and toss gently until well coated.

In food processor or blender, place bread and pulse a few times to produce coarse crumbs. In a medium skillet, heat remaining oil over medium-high heat. Stir in breadcrumbs and garlic. Sauté about 1½ - 2 minutes until browned and crisp. Remove from heat and let cool.

Top pasta with garlic crumbs and remaining basil. Serve.

Makes 8 servings.

Per serving: 180 calories, 6 g total fat (1 g saturated fat), 27 g carbohydrate, 5 g protein, 4 g dietary fiber, 25 mg sodium.

More Articles

More Articles

Amazon.com is pleased to have the Lymphoma Information Network in the family of Amazon.com associates. We've agreed to ship items...

The question ought to be what are myelodysplastic syndromes (MDS), since this is a group of similar blood and bone marrow diseases that...

Merkel Cell Carcinoma (MCC) is a very rare and aggressive skin cancer that usually develops when a person is in his or her 70s. It is...

Radiation Therapy Topics

...

At some point, the Seattle biotech company Cell Therapeutics Inc (CTI) should earn an entry in the Guinness Book of World Records for utter and...

Site Beginnings

This site was started as Lymphoma Resource Page(s) in 1994. The site was designed to collect lymphoma...

Three papers appearing in the journal Blood and pointing towards a regulator-suppressor pill could offer hope to blood cancer...

The US Food and Drug Administration (FDA) has granted a third so-called Breakthrough Therapy Designation for the investigational oral...

The US Food and Drug Administration today has approved an expanded use of Imbruvica (ibrutinib) in patients with...

The U.S. Food and Drug Administration has announced that it has granted "Breakthrough Therapy Designation" for the investigational agent...

According to a new study published in the Proceedings of the National Academy of Sciences, a team from the University of California, San...

Pharmacyclics has announced that the company has submitted a New Drug Application (NDA) to the US Food and Drug Administration (FDA) for...

New research suggests that frontline radioimmunotherapy...

Gilead Sciences has announced results of the company's Phase II study of its investigational compound idelalisib, an oral inhibitor of...

Sitemap